1 / 11

Inherited bleeding disorder of primary hemostasis

Inherited bleeding disorder of primary hemostasis. Von Willebrand Disease. Most common genetic bleeding d/o Consist of 3 types : Type I (70%-80%) and type III (rare) characterized by partial and virtually complete deficiency of vWF Type II reflect a qualitative defect in vWF function

tracy
Télécharger la présentation

Inherited bleeding disorder of primary hemostasis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Inherited bleeding disorder of primary hemostasis

  2. Von Willebrand Disease • Most common genetic bleeding d/o • Consist of 3 types : • Type I (70%-80%) and type III (rare) characterized by partial and virtually complete deficiency of vWF • Type II reflect a qualitative defect in vWF function • Bleeding time can be normal, difficult to diagnosed. • Diagnosed when these criterias are satisfied : • Positive bleeding history • Reduced level of vWF activity • Positive family history of vWD

  3. vWF concentration influenced by stress, exercise, blood group and race. • Blood type O has 25% reduced in vWF, increase likelihood to get vWD • Blood type AB has 25% increase in vWF, decrease likelihood to get vWD • Option of treatment if there is spontaneous bleeding episodes : • Desmopressin and transfusional therapy with plasma-derived vWF products

  4. Platelet function disorder • Maybe congenital or acquired • Common present with spontaneous mucocutaneous bleeding / bleeding after hemostatic challenge (trauma, surfgery) • Acquired : • Antiepileptic (valproate) & antidepressant → functional impairment of platelet • Antiplatelet (Aspirin) →platelet inhibiton for 5-7days • - systemic d/o ( uremia, Congenital heart dss, liver failure, leukemia ) → lead to platelet function defect • Congenital : • Inherited defect in receptors for platelet adhesion and aggregation • Defect in signaling platelet secretion • Defect in platelet metabolism

  5. Congenital deficiency of coagulation protein

  6. Hemophilia • Hemophilia A → deficiency in FVIII • Hemophilia B → deficiency in FIX • Primarily affect males, females may be symptomatic carrier • Criteria : • Prolonged PTT, normal PT,platelet count and bleeding time • Diagnosed by FVIII and FIX deficieny ( FVIII usually already at ‘adult’ level at birth, FIX low at birth need to monitor 4-6 months to diagnose)

  7. Clinical classification of hemophilia

  8. Treatment : • Episodic or prophylactic infusion of factor concentrates • Severe hemophilia : given prophylactic therapy to prevent chronic complication associated with frequent joint bleeding

  9. Acquired Bleeding Disorder

  10. Acquired vit K deficiency • Suspected in chronically ill children with malabsorption syndromes (cystic fibrosis, biliaryatresia, celiac disease) • Hemorrhagic disease of newborn (HDN), attributed to hepatic immaturity for synthesis of vit K clotting factor • DIC • involves simultaneous activation of coagulation and fibrinolytic system • Prolongations of coagulation screening test, thrombocytopenia, elevated concentration of fibrin degradation product • Associated with children who have acute promyelocytic leukemia

  11. Acquired inhibitors to coagulation proteins • FVIII and FIX rare in children • Acquired vWD reported in children with CHD with right to left shunt due to rapid clearance of large vWF multimer

More Related